New VC On The Block Oceanpine Raises US$200M For Its Second Fund
Oceanpine will continue to drive investments into deep tech
By Sharon Lewis
Venture capital (VC) firms in Southeast Asia have been slow to catch up with developments in the deep tech industry, with Singapore leading the charge thanks to proactive government initiatives that promote investments in this sector.
However, even in a robust startup economy such as Singapore, deep tech startups have only grown at a marginal rate of 5-6% in the last 15 years, as compared to other industries such as information and communications technology (ICT).
A part of the problem is that deep tech involves a heavy investment, and few investors are willing to take on the risk, or have the capacity to lead such investments in emerging tech. The trend is changing, albeit at a snail’s pace, with deep tech startups such as Holmusk and Mabworks Biotech making headlines with recently blockbuster financing rounds.
New VCs are foraying into deep tech investments, as well. One such VC, Oceanpine Capital, closed its second fund – Oceanpine Capital Fund II – at $200 million, the firm announced in a statement yesterday.
This is the first close of Fund II, and also the first time that Oceanpine has sourced funding from external Limited Partners (LP) since its founding, the statement noted. The firm is expecting a targeted internal rate of return of at least 30%, it added.
A 2016-founded venture capital investments firm headquartered in Beijing, Oceanpine has offices in Hong Kong and Silicon Valley as well. It focuses on early- to late-stage companies that have customer traction or are in the early revenue stage.
Oceanpine’s first closing LPs included technology entrepreneurs, asset management allocators, family offices, and Midas List venture capitalists. The statement, however, did not disclose further specifics.
So far, Oceanpine has pumped $500 million dollars into over 20 China and United States-based companies. The list includes Chinese artificial intelligence (AI) computing platform Enflame Technology, China-US based biotech startup Ansun Biopharma, and Beijing-based AI startup Horizon Robotics.
A chunk of its outflows have been sourced from its $400 million debut fund, all of which has been invested. While Fund II sought funding from external LPs, Oceanpine’s first fund was built entirely from the ‘internal’ resources of Founder Dave Chenn, the statement said.
Its first fund has also secured two exits and two Initial Public Offerings (IPOs), with a distributions to paid-in capital (DPI) of 45%. Three more of Oceanpine’s portfolio companies are slated to file for an IPO in a year’s time.
Additionally, the firm has already invested around $100 million from Fund II across six deals, including the recent $100 million Series B round for Enflame, and $123 million Series C round for biopharma startup Apexigen.
Similar to its previous fund, Oceanpine will continue to focus on making deep tech investments with Fund II, including in the Technology, Media and Telecom (TMT) sector as well as in biopharma.
Earlier this year, Oceanpine Capital recently held it first ‘investment salon’, an investor conference themed around Subscription-as-a-Service (SaaS) enterprises. Speakers included Managing Director of Artificial Intelligence Industry Fund of Hillhouse Capital Jian Zhou, and Chairman of Accenture Greater China Wei Zhu.
The deep tech sector is far from thriving yet, but investors are starting to take more notice of the sector, especially as a means to survive the current COVID-19 pandemic and fend off future crises. More money is definitely on its way to deep tech in Southeast Asia.
Header image by Miguel Á. Padriñán from Pexels